Turns out, patients with very small breast tumours can forgo lymph node biopsies.
A new study conducted by Allina Health explored the treatment options for patients with microinvasive breast cancer - tumours that are one mm or less in size (the thickness of a dime).
Physicians at the Virginia Piper Cancer Institute wanted to know if surgical procedures to test the lymph nodes for cancer were always necessary.
They examined the outcomes of 294 patients who were treated between 2001 and 2015. Only 1.5 percent had positive lymph nodes - indicating the rare possibility of metastatic cancer.
And the only patients with positive lymph nodes had microinvasive tumors that were associated with relatively large non-invasive tumors (ductal carcinoma in situ or DCIS).
"These findings allow surgeons to select which patients with microinvasive tumors may actually benefit from lymph node sampling while sparing other patients from this procedure," said Tamera Lillemoe, a study co-author.
The study appears in The Breast Journal.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
